Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To evaluate safety, visual acuity outcomes, persistence of choroidal neovascular leakage, and
the number of treatments of combination intravitreal bevacizumab and verteporfin photodynamic
therapy at standard or reduced fluence level in patients with subfoveal CNV due to
age-related macular degeneration.